Center Laboratories

Center Laboratories Debt

The Debt of Center Laboratories (4123.TWO) as of Nov 22, 2026 is 1.77 B TWD. In the previous year, Debt was 2.65 B TWD — a change of -33.18% (lower).

Debt

1.77 BTWD

YoY

-33.18%

Last updated:

In 2025, Center Laboratories's total debt was 1.77 B TWD, a -33.18% change from the 2.65 B TWD total debt recorded in the previous year.

The Center Laboratories Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt
Date
Debt
Jan 1, 2018
2.86 B TWD
Jan 1, 2019
4.37 B TWD
Jan 1, 2020
3.77 B TWD
Jan 1, 2021
5.27 B TWD
Jan 1, 2022
3.47 B TWD
Jan 1, 2023
5.62 B TWD
Jan 1, 2024
2.65 B TWD
Jan 1, 2025
1.77 B TWD
The Center Laboratories Debt history
YEARDebtYoY
1.77 BTWD-33.18%
2.65 BTWD-52.79%
5.62 BTWD+61.90%
3.47 BTWD-34.11%
5.27 BTWD+39.94%
3.77 BTWD-13.83%
4.37 BTWD+52.60%
2.86 BTWD-76.86%
12.38 BTWD+39.60%
8.87 BTWD+0.74%
8.80 BTWD+294.41%
2.23 BTWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Center Laboratories Stock analysis

What does Center Laboratories do? Center Laboratories Inc is a pharmaceutical manufacturer and distributor headquartered in Taipei City, Taiwan. Listed on the Taiwan Stock Exchange under ticker 4123.TWO and ISIN TW0004123005, the company engages in the manufacture, wholesale, and retail of western medicines. Its main product lines include dairy products and probiotic products. Center Laboratories distributes its offerings in both domestic and overseas markets. The company conducted its initial public offering on December 18, 2002. It operates within the Health Care sector, specifically in the Pharmaceuticals industry. The company's official website is https://www.centerlab.com.tw. Center Laboratories is one of the most popular companies on Eulerpool.

Debt Details

Understanding Center Laboratories's Debt Structure

Center Laboratories's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Center Laboratories's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Center Laboratories’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Center Laboratories’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Center Laboratories stock

Debt of Center Laboratories is 1.77 B TWD in 2025.

Debt of Center Laboratories changed from 2.65 B TWD to 1.77 B TWD, representing a -33.18% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Debt Center Laboratories since 2006 – with annual values, charts, and detailed analysis.

Debt's TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Debt's Center Laboratories historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Center Laboratories

All Key Metrics — Center Laboratories